Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies

被引:161
作者
Hu, Che-Ming J.
Fang, Ronnie H.
Luk, Brian T.
Zhang, Liangfang [1 ]
机构
[1] Univ Calif San Diego, Dept NanoEngn, San Diego, CA 92093 USA
基金
美国国家科学基金会;
关键词
N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER-DOXORUBICIN; ACCELERATED BLOOD CLEARANCE; LARGE UNILAMELLAR LIPOSOMES; TARGETED DRUG-DELIVERY; PEG CHAIN-LENGTH; PHASE-II TRIAL; IN-VIVO; COMPLEMENT ACTIVATION; SIALIC-ACID; GENEXOL-PM;
D O I
10.1039/c3nr05444f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Long-circulating polymeric nanotherapeutics have garnered increasing interest in research and in the clinic owing to their ability to improve the solubility and pharmacokinetics of therapeutic cargoes. Modulation of carrier properties promises more effective drug localization at the disease sites and can lead to enhanced drug safety and efficacy. In the present review, we highlight the current development of polymeric nanotherapeutics in the clinic. In light of the importance of stealth properties in therapeutic nanoparticles, we also review the advances in stealth functionalization strategies and examine the performance of different stealth polymers in the literature. In addition, we discuss the recent development of biologically inspired "self" nanoparticles, which present a differing stealth concept from conventional approaches.
引用
收藏
页码:65 / 75
页数:11
相关论文
共 169 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[3]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[4]   Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer [J].
Arimura, H ;
Ohya, Y ;
Ouchi, T .
BIOMACROMOLECULES, 2005, 6 (02) :720-725
[5]   The formation of biodegradable polymeric micelles from newly synthesized poly(aspartic acid)-block-polylactide AB-type diblock copolymers [J].
Arimura, H ;
Ohya, Y ;
Ouchi, T .
MACROMOLECULAR RAPID COMMUNICATIONS, 2004, 25 (06) :743-747
[6]   Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients [J].
Armstrong, Jonathan K. ;
Hempel, Georg ;
Koling, Susanne ;
Chan, Linda S. ;
Fisher, Timothy ;
Meiselman, Herbert J. ;
Garratty, George .
CANCER, 2007, 110 (01) :103-111
[7]  
Aryal S, 2013, NANOMEDICINE-UK, V8, P1271, DOI [10.2217/NNM.12.153, 10.2217/nnm.12.153]
[8]   Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy [J].
Aryal, Santosh ;
Hu, Che-Ming Jack ;
Zhang, Liangfang .
MOLECULAR PHARMACEUTICS, 2011, 8 (04) :1401-1407
[9]   Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Livaniou, E ;
Evangelatos, G ;
Ithakissios, DS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 259 (1-2) :115-127
[10]   Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (02) :456-468